Immunosuppressant-induced endothelial damage and pulmonary arterial hypertension

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 1, 2011, Pages 55-58

  Mathew, Rajamma ^a   Huang, Jing ^a   Katta, Umadevi S ^b   Krishnan, Usha ^a   Sandoval, Claudio ^b   Gewitz, Michael H ^a  

^a Maria Fareri Children's Hospital   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

acute respiratory distress syndrome; endothelial cells; Immunosuppressants; pulmonary arterial hypertension

Indexed keywords

BOSENTAN; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID; NIFEDIPINE; PREDNISONE; SILDENAFIL; TACROLIMUS; THYMOCYTE ANTIBODY; WARFARIN;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ARTICLE; CANCER REGRESSION; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOTHELIUM INJURY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HEART CATHETERIZATION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; LUNG BIOPSY; MALE; MINIMAL RESIDUAL DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STEROID THERAPY; THORAX RADIOGRAPHY;

CHILD, PRESCHOOL; CYCLOSPORINE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS;

EID: 78650841889     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181ec0ede     Document Type: Article

References (18)

1. Lamas S. Cellular mechanisms of vascular injury mediated by calcineurin inhibitors. Kidney Int. 2005;68:898-907.
2. Zoja C, Furci L, Ghilardi F, et al. Cyclosporin-induced endothelial cell injury. Lab Invest. 1986;55:455-462.
3. Grigg A, Buchanan-M, Whitford H. Late onset pulmonary arterial hypertension in association with graft-versus-host disease after allogeneic stem-cell transplantation. Am J Hematol. 2005;80:38-42.
4. Limsuwan A, Pakakasama S, Rochanawutanon M, et al. Pulmonary arterial hypertension after childhood cancer therapy and bone marrow transplantation. Cardiology 2006; 105:188-194.
5. Huang J, Wolk JH, Gewitz MH, et al. Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension. Exp Lung Res. 2010;36:57-66.
6. Huang J, Kaminski PM, Edwards JG, et al. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline- induced pulmonary artery hypertension. Am J Physiol. 2008;294:L1250-L1259.
7. Achcar RO, Demura Y, Rai PR, et al. Loss of caveolin-1 and heme oxygenase expression in severe pulmonary hypertension. Chest. 2006;129:696-705.
8. Cohen AW, Hnasko R, Schubert W, et al. Role of caveolae and caveolins in health and disease. Physiol Rev. 2004;84: 1341-1379.
9. Swanson SK, Born T, Zydowsky LD, et al. Cyclosporinmediated inhibition of bovine calcineurin by cyclophilins A and B. Proc Natl Acad Sci U S A. 1992;89:3741-3745.
10. Caramelo C, Alvarez-Arroyo MV, Yagü e S, et al. Cyclosporin A toxicity, and more: Vascular endothelial growth factor (VEGF) steps forward. Nephrol Dial Transplant. 2004;19: 285-288.
11. Navarro-Antolín J, Redondo-Horcajo M, Zaragoza C, et al. Role of peroxynitrite in endothelial damage mediated by Cyclosporine A. Free Radic Biol Med. 2007;42:394-403.
12. Lungu AO, Jin ZG, Yamawaki H, et al. Cyclosporin A inhibits flow-mediated activation of endothelial nitric oxide synthase by altering cholesterol content in caveolae. J Biol Chem. 2004;279:48794-48800.
13. Vassord C, Lapouméroulie C, Koumaravelou K, et al. Endothelial cells do not express GSTA1: Potential relevance to busulfan-mediated endothelial damage during haematopoietic stem cell transplantation. Eur J Haematol. 2008;80:299-302.
14. Kawut SM, Horn EM, Berekashvili KK, et al. Von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension. Chest. 2005;128: 2355-2362.
15. Patel HH, Zhang S, Murray F, et al. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J. 2007;21:2970-2979.
16. Hassan GS, Williams TM, Frank PG, et al. Caveolin-1- deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelinbased signal transduction. Am J Physiol. 2006;290: H2393-H2401.
17. Kawabe J, Okumura S, Lee MC, et al. Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Am J Physiol. 2004;286:H1845-H1852.
18. Sedding DG, Braun-Dullaeus RC. Caveolin-1: Dual role for proliferation of vascular smooth muscle cells. Trends Cardiovasc Med. 2006;16:50-55.